Kamilah Rashid is a Doctorate of Pharmacy Degree candidate at Mercer University College of Pharmacy. She completed her Bachelor of Science degree in chemistry from Spelman College and a post-baccalaureate biomedical research program at Arizona State University.
Eighty-seven percent of adults use the internet and 90 percent have cell phones, with 78 percent using smartphones. Over the years, the rising trend of people with access to the internet and those who are smartphone users aided in the exponential development of mobile applications. In this digital age, there is a constant demand for convenient access to databases, particularly those that are health, drug or regulatory-related, in part due to healthcare concerns in the US. Currently, there exist a vast number of mobile applications that fall within these categories. The majority of health related applications on the Android and Apple markets focus on the diagnosis of diseases and other conditions, cures for diseases, treatment or prevention of diseases, causing them to be defined as mobile medical devices according to the FDA standards. Additionally, the FDA supports the rapid provision of regulatory information to patients. In today’s competitive and highly regulated healthcare environment, it is essential to develop creative and innovative health related applications to address regulatory issues. Currently, there are no US mobile applications that provide a comprehensive review in addition to continuous updates on all facets of regulatory affairs. The development of a regulatory affairs mobile application that offers healthcare professionals and patients with critical information regarding regulation of clinical trials, safety issues, marketing approval applications, post-marketing activities and more, would help bridge the knowledge gap between patients, healthcare providers, and pharmaceutical companies.
Athanasia Varvaresou is an Associate Professor in department of Cosmetology at Technological Educational Institution of Athens, Greece.
Phthalic acid esters or phthalates are widely used by cosmetic industry to fix or hold color or fragrance, making the color or fragrance last longer and to provide a film or gloss. Secondly phthalates are used as plasticizers to impart flexibility to rigid polymers such as polyvinyl chloride (PVC), that are used for packaging of the final cosmetic products or even the row materials. Although some phthalates as di-n-butyl (DBP), benzylbutyl (BBP) di-(2-ethylhexyl)phthalate (DEHP) are banned under the cosmetics directive as CMR substances (carcinogenic, mutagenic or toxic for reproduction), other like diethyl phthalate (DEP) and dimethyl phthalate (DMP) are not banned in Europe but they are defined as contaminants to be controlled by the U.S. Environmental Protection Agency (EPA) together with di-n-octyl phthalate (DINP). Most perfumes contain DEP which is a well established perfume fixative and DMP a substance which is not used as cosmetic ingredient according to COLIPA. In this short study, we try to pause the questions regarding the safety of the usage of some phthalates in cosmetic and especially perfume industry, since perfumes are leave on cosmetics and there is a high potential of human exposure.